Blood Clot Awareness Month in the State of Georgia; March 2025; recognize
Summary
House Resolution 91 is a commemorative resolution that recognizes March 2025 as Blood Clot Awareness Month in the State of Georgia. The resolution ties the state observance to National Deep Vein Thrombosis and Pulmonary Embolism Awareness Month and cites public health data about the prevalence, severity, and preventability of blood clots. It highlights that blood clots can affect people of all ages and backgrounds, including infants, pregnant and postpartum women, cancer patients, surgical patients, and older adults.
The resolution does not create a new program, mandate, or regulatory requirement. Instead, it expresses the House’s support for public awareness efforts and directs the Clerk to distribute copies of the resolution to the public and press. Its practical effect is limited to official recognition and public education, with no direct change to Georgia statutes or agency duties.
Impact
HR 91 has no substantive legal effect on Georgia law and does not amend any code sections, appropriate funds, or impose obligations on state agencies, health providers, or local governments. Its impact is symbolic and educational: it formally designates March 2025 as Blood Clot Awareness Month in Georgia and encourages broader public attention to prevention, diagnosis, and treatment of blood clots, including deep vein thrombosis and pulmonary embolism.
Sentiment
The tone of the resolution and the available context indicate broad, positive support. The bill is framed as a public health awareness measure, with language emphasizing the seriousness of blood clots, their preventability, and the need for greater education at the local, state, and national levels. No committee debate, recorded votes, or opposition are provided, and the resolution’s commemorative nature suggests it is likely noncontroversial.
Contention
No specific points of contention are reflected in the bill text or the available legislative history. Because the resolution is purely declaratory and does not alter policy, funding, or regulation, there is no identified opposition from affected stakeholders. Any potential discussion would likely center on the value of awareness campaigns versus more direct public health interventions, but no such disagreement appears in the provided materials.